Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer.
MRI
Rectal cancer
TNM stage
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
27 Mar 2020
27 Mar 2020
Historique:
received:
16
09
2019
accepted:
17
03
2020
entrez:
29
3
2020
pubmed:
29
3
2020
medline:
17
12
2020
Statut:
epublish
Résumé
Various tumor characteristics might lead to inaccurate local MRI-defined stage of rectal cancer and the purpose of this study was to explore the clinicopathological factors that impact on the precision pre-treatment MRI-defined stage of rectal cancer. A retrospectively analysis was conducted in non-metastatic rectal cancer patients who received radical tumor resection without neoadjuvant treatment during 2007-2015 in the Sixth Affiliated Hospital of Sun Yat-sen University. Clinical T stage and N stage defined by pelvic enhanced MRI and pathological stage were compared and patients were subdivided into accurate-staging, over-staging and under-staging subgroups. Logistic regressions were used to explore risk factors for over-staging or under-staging. Five hundred fifty-one cases of patients were collected. Among them, 109 cases (19.4%) of patients were over-T-staged and 50 cases (8.9%) were under-T-staged, while 78 cases (13.9%) were over-N-staged and 75 cases (13.3%) were under-N-staged. Logistic regression suggested that pre-operative bowel obstruction was risk factor for over-T-staging (OR = 3.120, 95%CI: 1.662-5.857, P < 0.001) as well as over-N-staging (OR = 3.494, 95%CI: 1.797-6.794, P < 0.001), while mucinous adenocarcinoma was a risk factor for under-N-staging (OR = 4.049, 95%CI: 1.876-8.772, P < 0.001). Patients with larger tumor size were at lower risk for over-T-staging (OR = 0.837, 95%CI: 0.717-0.976, P = 0.024) and higher risk for over-N-staging (OR = 1.434, 95%CI: 1.223-1.680, P < 0.001). Bowel obstruction, mucinous adenocarcinoma and tumor size might have impact on the pre-operative MRI T staging or N staging of rectal cancer. Our results reminded clinicians to assess clinical stage individually in such rectal cancer patients.
Sections du résumé
BACKGROUND
BACKGROUND
Various tumor characteristics might lead to inaccurate local MRI-defined stage of rectal cancer and the purpose of this study was to explore the clinicopathological factors that impact on the precision pre-treatment MRI-defined stage of rectal cancer.
METHODS
METHODS
A retrospectively analysis was conducted in non-metastatic rectal cancer patients who received radical tumor resection without neoadjuvant treatment during 2007-2015 in the Sixth Affiliated Hospital of Sun Yat-sen University. Clinical T stage and N stage defined by pelvic enhanced MRI and pathological stage were compared and patients were subdivided into accurate-staging, over-staging and under-staging subgroups. Logistic regressions were used to explore risk factors for over-staging or under-staging.
RESULTS
RESULTS
Five hundred fifty-one cases of patients were collected. Among them, 109 cases (19.4%) of patients were over-T-staged and 50 cases (8.9%) were under-T-staged, while 78 cases (13.9%) were over-N-staged and 75 cases (13.3%) were under-N-staged. Logistic regression suggested that pre-operative bowel obstruction was risk factor for over-T-staging (OR = 3.120, 95%CI: 1.662-5.857, P < 0.001) as well as over-N-staging (OR = 3.494, 95%CI: 1.797-6.794, P < 0.001), while mucinous adenocarcinoma was a risk factor for under-N-staging (OR = 4.049, 95%CI: 1.876-8.772, P < 0.001). Patients with larger tumor size were at lower risk for over-T-staging (OR = 0.837, 95%CI: 0.717-0.976, P = 0.024) and higher risk for over-N-staging (OR = 1.434, 95%CI: 1.223-1.680, P < 0.001).
CONCLUSION
CONCLUSIONS
Bowel obstruction, mucinous adenocarcinoma and tumor size might have impact on the pre-operative MRI T staging or N staging of rectal cancer. Our results reminded clinicians to assess clinical stage individually in such rectal cancer patients.
Identifiants
pubmed: 32216771
doi: 10.1186/s12885-020-06761-0
pii: 10.1186/s12885-020-06761-0
pmc: PMC7099769
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
253Subventions
Organisme : National Natural Science Foundation
ID : 81800484
Organisme : Natural Science Foundation of Guangdong Province
ID : 2018A030310268
Organisme : National Key Clinical Discipline in general surgery
ID : -
Références
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901
pubmed: 30006429
J Cancer. 2015 May 26;6(7):636-42
pubmed: 26078794
Int J Oncol. 1999 Jun;14(6):1057-61
pubmed: 10339657
J Surg Oncol. 2001 Aug;77(4):282-3
pubmed: 11473380
Ann Surg Oncol. 2012 Sep;19(9):2814-21
pubmed: 22476818
J Comput Assist Tomogr. 2003 Jan-Feb;27(1):48-55
pubmed: 12544243
Curr Probl Diagn Radiol. 2017 May - Jun;46(3):234-241
pubmed: 28089690
Dis Colon Rectum. 2016 Dec;59(12):1200-1208
pubmed: 27824706
Dis Colon Rectum. 2014 Apr;57(4):449-59
pubmed: 24608301
Int J Biol Sci. 2016 Jul 17;12(8):1022-31
pubmed: 27489505
Ann Surg Oncol. 2012 Jul;19(7):2212-23
pubmed: 22271205
Cancer. 1976 Apr;37(4):1891-1900
pubmed: 177180
Surg Clin North Am. 2017 Jun;97(3):587-604
pubmed: 28501249
Gastroenterol Rep (Oxf). 2016 Dec 26;5(3):226-231
pubmed: 28025227
Oncol Lett. 2015 Jun;9(6):2680-2686
pubmed: 26137128
Dis Colon Rectum. 2014 Jan;57(1):32-8
pubmed: 24316943
Curr Treat Options Oncol. 2017 Sep 25;18(10):64
pubmed: 28948490
AJR Am J Roentgenol. 2004 Feb;182(2):431-9
pubmed: 14736677